Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

INNOVATIVE PHARMACEUTICAL BIOTECH LIMITED

領航醫藥及生物科技有限公司

(Incorporated in the Cayman Islands and continued in Bermuda with limited liability)

(Stock Code: 399) CHANGE OF NAME OF PRINCIPAL SHARE REGISTRAR AND TRANSFER AGENT IN BERMUDA

The board of directors (the "Board") of Innovative Pharmaceutical Biotech Limited (the "Company") announces that the principal share registrar and transfer agent of the Company in Bermuda, Codan Services Limited, has changed its name to Conyers Corporate Services (Bermuda) Limited with effect from 31 March 2017. The address of the principal share registrar and transfer agent of the Company in Bermuda remains unchanged.

Hong Kong, 12 April 2017

By Order of the Board

Innovative Pharmaceutical Biotech Limited Tang Rong

Executive Director

As at the date of this announcement, the Board comprises Ms. Jiang Nian (chairman & non-executive director), Mr. Gao Yuan Xing (executive director), Mr. Tang Rong (executive director), Ms. Huang He (executive director), Ms. Xiao Yan (non-executive director), Ms. Wu Yanmin (non-executive director), Ms. Chen Weijun (independent non-executive director), Dr. Zhang Zhihong (independent non-executive director) and Mr. Wang Rongliang (independent non-executive director).

Innovative Pharmaceutical Biotech Limited published this content on 12 April 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 12 April 2017 10:31:18 UTC.

Original documenthttp://file.irasia.com/listco/hk/ipb/announcement/a170412.pdf

Public permalinkhttp://www.publicnow.com/view/9287F505F7AC387C7832B882CD9541D7107B141C